Barwon Anacacia Private Equity IV has been established to allow wholesale investors to access Anacacia’s leading Australian SME private equity strategy.

Barwon ICG Strategic Equity V Fund has been established to allow wholesale investors to access ICG’s market-leading GP secondaries investment strategy.

The Barwon Leeds Equity Partners VIII Fund is a fixed-life fund for investors seeking attractive private equity returns from investing in the Knowledge Industries.

The Barwon VC 16 Fund is a fund established for the purposes of making a direct investment to a leading global venture capital fund (Underlying Fund).

The Barwon Leeds Equity Partners VII Fund is a fixed-life fund for investors seeking attractive private equity returns from investing in the Knowledge Industries.

The Barwon AP Impact Fund is a fixed-life fund for investors seeking attractive private equity returns from global impact investing.

The fund provides investors with exposure to the global opportunistic real estate strategy managed by a leading global alternative asset manager with an excellent long-term track-record.

The Barwon Kent Pharmaceuticals Investment Trust is a fund established for the purposes of making a direct co-investment in Kent Pharmaceuticals alongside Duke Street.

The Barwon A-Rosa Investment Fund is a fund established for the purposes of making a direct co-investment in A-Rosa alongside Duke Street.

The Barwon VC 15 Fund is a fund established for the purposes of making a direct investment to a leading global venture capital fund (Underlying Fund).